Expanded Access of Occlutech's Atrial Flow Regulator
Conditions Not listed
Trial statusAvailable
Trial phaseNot listed
Trial typeExpanded Access
Biological sexAll
AgeNot listed
SponsorOcclutech International AB
About this trial
Occlutech AFR use allowed per FDA's Expanded Access program.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
None
Trial design
Treatments tested in this trial
Catheter implantation of Occlutech AFR device
Device
Treatment groups
No treatment groups listed
Trial outcomes
This trial has no outcomes listed.Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov